Status:

TERMINATED

Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort

Lead Sponsor:

Probi AB

Conditions:

Abdominal Discomfort

Eligibility:

All Genders

2-12 years

Phase:

PHASE2

Brief Summary

To demonstrate benefit and tolerability of a probiotic product in infants with abdominal discomfort.

Eligibility Criteria

Inclusion

  • Male or female singleton
  • ≥ 2 weeks and ≤ 12 weeks of age
  • Exclusively breastfed at screening
  • Abdominal discomfort (infant colic) in the week prior to enrollment, according to the statement of the parent(s) and/or guardian(s)
  • Episodes of fussy crying that lasted at least 3 hours a day for at least 3 days in the 7 days prior to enrollment, according to the statement of the parent(s) and/or guardian(s)
  • Voluntary, written informed consent of the parent(s) and/or guardian(s) to participate in the study
  • Born at full term (37-42 after last menstruation period)
  • Birth weight: 2500 - 4500 g
  • Weight-for-age ≥ 3th and ≤ 97th percentile according to WHO growth tables / charts
  • Apparently healthy at birth (Apgar ≥ 8) and at screening visit
  • No major complications during pregnancy or at birth
  • Mother 19-45 years of age at childbirth
  • Ability of parent(s) and/or guardian(s) to attend visits, interviews and willingness to fill out questionnaires

Exclusion

  • Intolerance to investigational product/its ingredients
  • Severe medical condition or illness, congenital abnormality
  • Gastrointestinal disorders (e.g. reflux esophagitis)
  • Intake of probiotics and/or antibiotics in the week preceding recruitment and during the study
  • Formula feeding at screening/randomisation
  • Allergy or atopic disease (family history)
  • Participation in another study
  • Mother's health condition that may interfere with her ability to take care of her infant
  • Mother affected by hepatitis B, HIV or Guillain-Barré Syndrome
  • Use of antibiotics by the mother in the week

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT01893814

Start Date

April 1 2013

Last Update

September 22 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charité Virchow Hospital

Berlin, Germany, 13353